Intramuscular edema as a complication of treatment with imatinib [1]

Leukemia

Volumn 17, Issue 4, 2003, Pages 804-805

  Shimazaki, C ^a   Ochiai, N ^a   Uchida, R ^a   Fuchida, S I ^a   Okano, A ^a   Ashihara, E ^a   Inaba, T ^a   Fujita, N ^a   Nakagawa, M ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DIURETIC AGENT; HYDROXYUREA; IMATINIB;

ADULT; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COMPARTMENT SYNDROME; DEPRESSION; EYELID EDEMA; FLUID RETENTION; HUMAN; LEG EDEMA; LETTER; MALE; MUSCLE CRAMP; MUSCLE DENERVATION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFYING MYOSITIS; PERICARDIAL EFFUSION; PHILADELPHIA 1 CHROMOSOME; PLEURA EFFUSION; PRIORITY JOURNAL; RHABDOMYOLYSIS; SICKLE CELL CRISIS; TISSUE PRESSURE; VOMITING;

EID: 0037398998     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402868     Document Type: Letter

References (7)

1. Deninger M, Goldman J, Melo J. The molecular biology of chronic myelogenous leukemia. Blood 2000; 96: 3343-3356.
2. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031-1037.
3. Kantarjian H, Sawyers CL, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645-652.
4. Ebnoether M, Stentoft J, Ford J, Buhl L, Gratwohl A. Cerebral oedema as a possible complication of treatment with imatinib. Lancet 2002; 359: 1751-1752.
5. Esmaeli B, Prieto VG, Butler CE, Kim SK, Ahmadi MA, Kantarjian HM et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 2002; 95: 881-887.
6. May DA, Disler DR, Jones EA, Balkisson AA, Manaster BL. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000; 20: S295-S315.
7. Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001; 61: 2929-2934.